Amway (Malaysia) Holdings Berhad operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Amway (Malaysia) Holdings Berhad with three other
drug stores in Asia:
Tibet Rhodiola Pharmaceutical Holding Company
sales of 1.38 billion Chinese Renmimbi [US$201.38 million]
of which 62%
was Pharmaceutical Business Trade),
Hua Xia Healthcare Holdings Limited
of Hong Kong
(1.78 billion Hong Kong Dollars [US$229.54 million]
of which 88%
was Pharmaceutical Wholesale), and
China Pioneer Pharma Holdings Ltd
based in China
(1.46 billion Chinese Renmimbi [US$213.12 million]
of which 59%
was Products sold via the provision of co-pr).
Amway (Malaysia) Holdings Berhad reported sales of 1.02 billion Malaysian Ringgits (US$228.52 million)
December of 2015.
increase of 19.2%
versus 2014, when the company's sales were 855.80 million Malaysian Ringgits.
Sales at Amway (Malaysia) Holdings Berhad have increased during each of the previous five years
(and since 2010, sales have increased a total of 42%).